Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa

References

• Abe K, Shoji M, Chen J, Bierhaus A, Danave I, Micko C, Casper K, Dillehay DL, Nawroth PP, Rickles FR. Regulation of vascular endothelial growth factor and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci USA 1999; 96(15)8663–8668
   PubMed Web of Science ®Google Scholar
• Adams BK, Ferstl EM, Davis MC, Herold M, Kurtkaya S, Camalier RF, Hollingshead MG, Kaur G, Sausville EA, Rickles FR, Snyder JP, Liotta DC, Shoji M. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. Bioorg Med Chem 2004; 12(14)3871–3883
   PubMed Web of Science ®Google Scholar
• Adams BK, Cai J, Armstrong J, Herold M, Lu YJ, Sun A, Snyder JP, Liotta DC, Jones DP, Shoji M. EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anticancer Drugs 2005; 16(3)263–275
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 2003; 23(1A)363–398
   PubMed Web of Science ®Google Scholar
• Ames MA, Reid JM. 2004. Pharmacokinetic Studies of EF24 (NSC D-716993) in Mice. Rapid Access to the NCI-Discovery (RAND) program, Contract N01-CM07105, May 4.
   Google Scholar
• Armesilla AL, Lorenzo E, Gomez del Arco P, Martinez-Martinez S, Alfranca A, Redondo JM. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: A role for tissue factor gene expression. Mol Cell Biol 1999; 19(3)2032–2043
   PubMed Web of Science ®Google Scholar
• Awasthi S, Pandya U, Singhal SS, Lin JT, Thiviyanathan V, Seifert WE, Jr., Awasthi YC, Ansari GA. Curcumin–glutathione interactions and the role of human glutathione S-transferase P1-1. Chem Biol Interact 2000; 128(1)19–38
   PubMed Web of Science ®Google Scholar
• Callander NS, Varki N, Rao LV. Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992; 70(5)1194–1201
   PubMed Web of Science ®Google Scholar
• Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. Turmeric and curcumin: Biological actions and medicinal applications. Curr Sci 2004; 87(1)44–53
   Web of Science ®Google Scholar
• Chen J, Bierhaus A, Schiekofer S, Andrassy M, Chen B, Stern DM, Nawroth PP. Tissue factor—a receptor involved in the control of cellular properties, including angiogenesis. Thromb Haemost 2001; 86(1)334–345
   PubMed Web of Science ®Google Scholar
• Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration. J Exp Med 1990; 172(6)1535–1545
   PubMed Web of Science ®Google Scholar
• Contrino J, Hair GA, Schmeizl MA, Rickles FR, Kreutzer DL. In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor VIIa as probes. Am J Pathol 1994; 145(6)1315–1322
   PubMed Web of Science ®Google Scholar
• Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease. Nat Med 1996; 2(2)209–215
   PubMed Web of Science ®Google Scholar
• Dickinson CD, Kelly CR, Ruf W. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci USA 1996; 93(25)14379–14384
   PubMed Web of Science ®Google Scholar
• Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134(5)1087–1097
   PubMed Web of Science ®Google Scholar
• Elvira C, Gallardo A, Roman JS, Cifuentes A. Covalent plolymer–drug conjugates. Molecules 2005; 10(1)114–125
   PubMed Web of Science ®Google Scholar
• Flossel C, Luther T, Muller M, Albrecht S, Kasper M. Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue. Histochem 1994; 101(6)449–453
   Google Scholar
• Folkman J. Angiogenesis. Harrison's principles of internal medicine15th ed., E Braunwald, AS Fauci, DL Kasper, SL Hauser, DL Longo, JL Jameson. McGraw Hill, New York, USA 2001; 517–530
   Google Scholar
• Folkman J. Angiogenesis: An organizing principle for drug discovery. Nat Rev Drug Discov 2007; 6(4)273–286
   PubMed Web of Science ®Google Scholar
• Forster Y, Meye A, Albrecht S, Schwenzer B. Tissue factor and tumor: Clinical and laboratory aspects. Clin Chim Acta 2006; 364(1–2)12–21
   PubMed Web of Science ®Google Scholar
• Hansen CB, Pyke C, Petersen LC, Rao LV. Tissue factor-mediated endocytosis, recycling and degradation of factor VIIa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factor. Blood 2001; 97(6)1712–1720
   PubMed Web of Science ®Google Scholar
• Hu Z, Sun Y, Garen A. Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model. Proc Natl Acad Sci USA 1999; 96(14)8161–8166
   PubMed Web of Science ®Google Scholar
• Huang X, Molema G, King S, Watkins L, Edgington TS, Thorpe PE. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 1997; 275(5299)547–550
   PubMed Web of Science ®Google Scholar
• Iakhiaev A, Pendurthi UR, Voigt J, Ezban M. Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor. J Biol Chem 1999; 274(52)36995–37003
   PubMed Web of Science ®Google Scholar
• Jilma B, Marsik C, Mayr F, Graninger MT, Taylor FB, Jr., Ribel MC. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans. Clin Pharm Therap 2002; 72(4)403–410
   PubMed Web of Science ®Google Scholar
• Kakkar AK, Lemoine NR, Scully MF, Tebbutt S, Williamson RC. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg 1995; 82(8)1101–1104
   PubMed Web of Science ®Google Scholar
• Lev EI, Marmur JD, Zdravkovic M, Osende JI, Robbins J, Delfin JA, et al. Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: An ex vivo human study. Arterioscler Thromb Vasc Biol 2002; 22(6)1036–1041
   PubMed Web of Science ®Google Scholar
• Mechtcheriakova D, Wlachos A, Holzmuller H, Binder BR, Hofer E. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. Blood 1999; 93(11)3811–3823
   PubMed Web of Science ®Google Scholar
• Morphy R, Kay C, Rankovic Z. From magic bullets to designed multiple ligands. Drug Discov Today 2004; 9(15)641–651
   PubMed Web of Science ®Google Scholar
• Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71(1)1–8
   PubMed Web of Science ®Google Scholar
• Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376(6535)37–43
   PubMed Web of Science ®Google Scholar
• Nicolaisen EM, Kristensen H, Kristensen A, Hedner U. Evaluation of potential antigenicity of active-site-inhibited recombinant human FVIIa (FFR-rFVIIa) in an immune-tolerant rat model. Thromb Haemost 2002; 87(5)836–839
   PubMed Web of Science ®Google Scholar
• O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79(2)315–328
   PubMed Web of Science ®Google Scholar
• Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and fibroblast growth factor. Lab Invest 1992; 67(4)519–528
   PubMed Web of Science ®Google Scholar
• Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, Scudiero DA, Monks A, Boyd MR. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst 1990; 82(13)1113–1118
   PubMed Web of Science ®Google Scholar
• Sevinsky JR, Rao LV, Ruf W. Ligand-induced protease receptor translocation into caveolae: A mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol 1996; 133(2)293–304
   PubMed Web of Science ®Google Scholar
• Shan S, Lockhart AC, Saito WY, Knapp AM, Laderoute KR, Dewhirst MW. The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats. Clin Cancer Res 2001; 7(8)2590–2596
   PubMed Web of Science ®Google Scholar
• Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Andreas J, Gescher AJ, Steward WP. Pharmacodynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001; 7(7)1894–1900
   PubMed Web of Science ®Google Scholar
• Shoji M, Hancock WW, Abe K, Micko C, Casper KA, Baine RM, Wilcox JN, Danave I, Dillehay DL, Matthews E, Contrino J, Morrissey JH, Gordon S, Edgington TS, Kudryk B, Kreutzer DL, Rickles FR. Activation of coagulation and angiogenesis in cancer: Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol 1998; 152(2)399–411
   PubMed Web of Science ®Google Scholar
• Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82(13)1107–1112
   PubMed Web of Science ®Google Scholar
• Sorensen BB, Persson E, Freskgard PO, Kjalke M, Ezban M, Williams T, Rao LV. Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor. J Biol Chem 1997; 272(18)11863–11868, [erratum appears in J Biol Chem 1997 June 27;272(26):16708]
   PubMed Web of Science ®Google Scholar
• Sun A, Shoji M, Lu YJ, Liotta DC, Snyder JP. Synthesis of EF24-tripeptide chloromethyl ketone: A novel curcumin-related anticancer drug delivery system. J Med Chem 2006; 49(11)3153–3158
   PubMed Web of Science ®Google Scholar
• Takano S, Tsuboi K, Tomono Y, Mitsui Y, Nose T. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Br J Cancer 2000; 82(12)1967–1973
   PubMed Web of Science ®Google Scholar
• Vasey PA, Kaye SB, Morrison R, Twelves C, Wilson P, Duncan R, et al. Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: First member of a new class of chemotherapeutic agents–drug–polymer conjugates. Cancer Res. Campaign Phase I/II Committee. Clin Cancer Res 1999; 5(1)83–94
   PubMed Web of Science ®Google Scholar
• Wan YL, Rong L, Liu YC, Yao HW, Wang X, Wu T, Pan YS, Zhu J. [The role of tissue factor in the invasion and metastasis of colorectal carcinoma cells]. Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery] 2005; 43(19)1265–1267, [Chinese] [English Abstract]
   Google Scholar
• Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86(8)2839–2843
   PubMed Web of Science ®Google Scholar
• Williams EB, Krishnaswamy S, Mann KG. Zymogen/enzyme discrimination using peptide chloromethyl ketones. J Biol Chem 1989; 264(13)7536–7545
   PubMed Web of Science ®Google Scholar
• Zhang SZ, Lipsky MM, Trump BF, Hsu IC. Neutral red (NR) assay for cell viability and xenobiotic-induced cytotoxicity in primary cultures of human and rat hepatocytes. Cell Biol Toxicicol 1990; 6(2)219–234
   PubMed Web of Science ®Google Scholar
• Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994; 94(3)1320–1327
   PubMed Web of Science ®Google Scholar
• Zhang Y, Deng Y, Wendt T, Liliensiek B, Bierhaus A, Greten J, He W, Chen B, Hach-Wunderle V, Waldherr R, Ziegler R, Mannel D, Stern DM, Nawroth PP. Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma. J Clin Invest 1996; 97(10)2213–2224
   PubMed Web of Science ®Google Scholar
• Zhang J, Ding J, Zhang X, Shao X, Hao Z. Regulation of vascular endothelial growth factor (VEGF) production and angiogenesis by tissue Factor (TF) in SGC-7901 gastric cancer cells. Cancer Biol Ther 2005; 4(7)769–772
   PubMed Web of Science ®Google Scholar
• Zamai M, vandeVen M, Farao M, Gratton E, Ghiglieri A, Castelli MG, et al. Camptothecin poly[N-(2-hydroxypropyl) methacrylamide] copolymers in antitopoisomerase-I tumor therapy: Intratumor release and antitumor efficacy. Mol Cancer Ther 2003; 2(1)29–40
   PubMed Web of Science ®Google Scholar
• Zhou JN, Ljungdahl S, Shoshan MC, Swedenborg J, Linder S. Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF–ERK signaling pathway. Mol Carcinog 1998; 21(4)234–243
   PubMed Web of Science ®Google Scholar
• Zucker S, Mirza H, Conner CE, Lorenz AF, Drews MH, Bahou WF, Jesty J. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 1998; 75(5)780–786
   PubMed Web of Science ®Google Scholar